PPARG and fatty liver disease: The genetic deletion of Pparγ in livers of either ob/ob [31] or AZIP-F-1 [32] mice significantly alleviated the development of hepatic steatosis, which was independent of the existence of hyperglycemia or hyperinsulinemia.